{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:50:53Z","timestamp":1790974253417,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-019-0197-5","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T19:16:24Z","timestamp":1553022984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Charlotte","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Lystlund","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine Lindhardt","family":"Plesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Monrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hamilton-Dutoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"d\u2019Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5089-3271","authenticated-orcid":false,"given":"Maja","family":"Ludvigsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"197_CR1","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","volume":"25","author":"S Montoto","year":"2007","unstructured":"Montoto, S. et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J. Clin. Oncol. 25, 2426\u20132433 (2007).","journal-title":"J. Clin. Oncol."},{"key":"197_CR2","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","volume":"26","author":"AJ Al-Tourah","year":"2008","unstructured":"Al-Tourah, A. J. et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma. J. Clin. Oncol. 26, 5165\u20135169 (2008).","journal-title":"J. Clin. Oncol."},{"key":"197_CR3","doi-asserted-by":"crossref","unstructured":"Conconi A., et al. Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br. J. Haematol. 157, 188\u2013196 (2012).","DOI":"10.1111\/j.1365-2141.2012.09054.x"},{"key":"197_CR4","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","volume":"31","author":"BK Link","year":"2013","unstructured":"Link, B. K. et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource. J. Clin. Oncol. 31, 3272\u20133278 (2013).","journal-title":"J. Clin. Oncol."},{"key":"197_CR5","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1200\/JCO.2009.26.1693","volume":"28","author":"T Relander","year":"2010","unstructured":"Relander, T. et al. Prognostic factors in follicular lymphoma. J. Clin. Oncol. 28, 2902\u20132913 (2010).","journal-title":"J. Clin. Oncol."},{"key":"197_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.beha.2017.10.006","volume":"31","author":"T Lackraj","year":"2018","unstructured":"Lackraj, T., Goswami, R. & Kridel, R. Pathogenesis of follicular lymphoma. Best. Pract. Res. Clin. Haematol. 31, 2\u201314 (2018).","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"197_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1044-579X(03)00015-4","volume":"13","author":"IS Lossos","year":"2003","unstructured":"Lossos, I. S. & Levy, R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin. Cancer Biol. 13, 191\u2013202 (2003).","journal-title":"Semin. Cancer Biol."},{"key":"197_CR8","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1182\/blood-2008-08-174839","volume":"113","author":"E Carlotti","year":"2009","unstructured":"Carlotti, E. et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood 113, 3553\u20133557 (2009).","journal-title":"Blood"},{"key":"197_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/sj.leu.2403802","volume":"19","author":"AJ Davies","year":"2005","unstructured":"Davies, A. J. et al. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia 19, 1459\u20131465 (2005).","journal-title":"Leukemia"},{"key":"197_CR10","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1182\/bloodadvances.2018017673","volume":"2","author":"C Madsen","year":"2018","unstructured":"Madsen, C. et al. Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study. Blood Adv. 2, 1562\u20131571 (2018).","journal-title":"Blood Adv."},{"key":"197_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.18","volume":"5","author":"M Ludvigsen","year":"2015","unstructured":"Ludvigsen, M. et al. Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma. Blood Cancer J. 5, e293 (2015).","journal-title":"Blood Cancer J."},{"key":"197_CR12","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli, A. & Li, S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci. 68, 3033\u20133046 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"197_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/01.LAB.0000053913.85892.E9","volume":"83","author":"S De Vos","year":"2003","unstructured":"De Vos, S. et al. Gene expression profile of serial samples of transformed B-cell lymphomas. Lab Invest. 83, 271\u2013285 (2003).","journal-title":"Lab Invest."},{"key":"197_CR14","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1182\/blood-2002-07-2119","volume":"101","author":"JA Martinez-Climent","year":"2003","unstructured":"Martinez-Climent, J. A. et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 101, 3109\u20133117 (2003).","journal-title":"Blood"},{"key":"197_CR15","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.4049\/jimmunol.1300179","volume":"190","author":"SC Cha","year":"2013","unstructured":"Cha, S.-C. et al. Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen. J. Immunol. 190, 4887\u20134898 (2013).","journal-title":"J. Immunol."},{"key":"197_CR16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3109\/10428194.2010.551793","volume":"52","author":"SA Maxwell","year":"2011","unstructured":"Maxwell, S. A., Cherry, E. M. & Bayless, K. J. Akt, 14-3-3\u03b6, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma. Leuk. Lymphoma 52, 849\u2013864 (2011).","journal-title":"Leuk. Lymphoma"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-019-0197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-019-0197-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-019-0197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:11:47Z","timestamp":1671207107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-019-0197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1038\/s41408-019-0197-5","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"35"}}